Post-Operative Pain Management Market Overview
The post-operative pain management market is anticipated to reach USD 4,550 Million by 2030 at 6.80% CAGR during the forecast period 2022-2030, reveals the latest Market Research Future (MRFR) report. Post-operative pain is unpleasant and annoying, which, if not treated correctly and on time, can result in chronic pain, which may last for months. Post-operative pain is a common adverse outcome owing to physical distress, prolonged hospital stays, and the growing incidence of readmissions of patients after surgery. Post-operative pain management helps in minimizing patient discomfort, facilitating early mobilization, functional recovery along with preventing acute pain turning into chronic pain. Besides, it also helps to lessen the possibility of pulmonary, cardiac, and neuropathic pain complications, low cost of care, and cut down the risk of thrombosis.
The pain arising post-surgery due to tissue injury and muscle spasm in a patient requires special attention because such kind of pain is a symptom that indicates a patient’s undiagnosed discomforts after surgery. This acute post-operative pain often tends to transform into chronic pain if not managed properly. Dovepress, a pain research journal, states that around 80% patients in the United States receive the desirable postoperative pain treatment. Enhanced post-operative pain management contributes to a patient’s quick rehabilitation and hence, sooner hospital discharge thereby, reducing medical expenses of the patient. This increases patient’s satisfaction which is expected to contribute largely to the global Post-Operative Pain Management Market expansion. Increasing prevalence of diseases that require surgical attention, like laparoscopic cholecystectomy and rise in the number of patients afflicted with diseases like cancer are other factors impelling the market growth. The rise in necessity of providing effective pain management with minimum side effect is creating immense opportunity for the market key players to invest in research and development activities which are anticipated to positively impact the postoperative pain management market expansion.
Various factors are propelling the post-operative pain management market growth. These factors, as per the new Market Research Future (MRFR) report, include growing incidence of diseases that need surgical treatments, development of novel drugs for quick pain relief, increased R&D activities to develop high-quality post-operative pain management solutions with minimum side effects, increasing prevalence of various chronic diseases such as cardiovascular diseases, renal diseases, cancer, and others, and increase in geriatric population. Additional factors pushing market growth include the increasing number of cancer patients and burgeoning demand for pain control devices and drugs.
The MRFR report provides an all-inclusive segmental analysis of the post-operative pain management market on the basis of target area, application, product, and pain type.
Based on pain type, the post-operative pain management market is segmented into severe pain, moderate pain, and acute pain.
Based on the product, the market is segmented into opioids, COX-2 inhibitors, antiepileptic drugs, non-steroidal anti-inflammatory drugs, and other analgesics.
Based on the application, the market is segmented into migraine, musculoskeletal pain, neuropathic pain, arthritic pain, cancer pain, and others. Of these, the cancer pain segment will have the largest share in the market over the forecast period.
Based on target area, the market is segmented into arms, hand, legs, back, and others.
By region, the post-operative pain management market report covers the latest trends and growth opportunities across the Asia Pacific (APAC), the Americas, Europe, and the Middle East and Africa. Of these, the Americas will dominate the market over the forecast period. This is chiefly on account of the presence of well-developed healthcare infrastructure in the region and the huge patient pool undergoing surgical procedures.
The market in Europe is predicted to have the second-largest share in the market over the forecast period. This is chiefly on account of the increasing R&D activities for the launch of new drugs with minimal side-effects.
The market in the APAC region is predicted to grow at the fastest pace over the forecast period. This is chiefly on account of the growing incidence of chronic diseases that needs surgical treatment coupled with an increase in the geriatric population.
The market in the MEA is predicted to have steady growth over the forecast period. This is chiefly on account of poor primary health care services, especially in the region’s underdeveloped areas and lack of awareness.
Teva Pharmaceutical Industries Ltd. (Israel), Eli Lilly (U.S), Pfizer (U.S), Johnson & Johnson (U.S), Purdue Pharma (U.S), Endo Pharmaceuticals Plc. (U.S), Forest Laboratories Inc. (U.S), GlaxoSmithKline Plc. (UK), F. Hoffmann-La Roche Ltd. (Switzerland), Baxter International Inc. (US), and Valeant Pharmaceuticals International Inc. (Canada) are the post-operative pain management market Players.
April 2019: American Society of Regional Anesthesia and Pain Medicine (ASRA) reported that regional anaesthesia with lidocaine infusion reduces postoperative pain for patients undergoing primary hip arthroplasty, according to research from Stanford University in Stanford, CA.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071